Current Drug Metabolism


Ming Hu
University of Houston
College of Pharmacy
Houston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet Our Editorial Board Member free to download

Volume:21   Issue: 14
Pp: 1069-1069
Su-Jun Lee
DOI: 10.2174/138920022114201230141909
Published on: 30 December, 2020

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases & their Metabolic Profiling-Part 2 free to download

Volume:21   Issue: 14
Pp: 1070-1071
Bairong Shen and Rajeev K. Singla
DOI: 10.2174/138920022114201230142204
Published on: 30 December, 2020

Recent Advances in Treatment of Childhood Obesity

Volume:21   Issue: 14
Pp: 1072-1078
Walter Milano, Paola Ambrosio, Francesca Carizzone, Walter Di Munzio, Valeria De Biasio and Anna Capasso*
DOI: 10.2174/1389200221666200817112311
Published on: 30 December, 2020

Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections

Volume:21   Issue: 14
Pp: 1079-1090
Ammara Riaz, Azhar Rasul*, Nazia Kanwal, Ghulam Hussain, Muhammad Ajmal Shah*, Iqra Sarfraz, Rubab Ishfaq, Rabia Batool, Fariha Rukhsar and Şevki Adem
DOI: 10.2174/1389200221999200728144801
Published on: 30 December, 2020

Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review

Volume:21   Issue: 14
Pp: 1091-1116
Ajmer Singh Grewal, Komal Thapa, Neha Kanojia, Neelam Sharma and Sukhbir Singh*
DOI: 10.2174/1389200221666201016124125
Published on: 30 December, 2020

Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration

Volume:21   Issue: 14
Pp: 1117-1126
Mengfan Zhao, Ziwei Jing, Lin Zhou, Hongyu Zhao, Qiuzheng Du* and Zhi Sun*
DOI: 10.2174/1389200221999201111193910
Published on: 30 December, 2020

Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters

Volume:21   Issue: 14
Pp: 1127-1135
Slobodan Rendic* and Frederick Peter Guengerich
DOI: 10.2174/1389200221999201208211537
Published on: 30 December, 2020

Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application

Volume:21   Issue: 14
Pp: 1136-1143
Javed Ahmad*, Md. Rizwanullah, Saima Amin, Musarrat Husain Warsi, Mohammad Zaki Ahmad and Md. Abul Barkat
DOI: 10.2174/1389200221666200719003304
Published on: 30 December, 2020

Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer’s Disease

Volume:21   Issue: 14
Pp: 1144-1151
Pallavi Singh Chauhan, Dhananjay Yadav*, Bhupendra Koul, Yugal Kishore Mohanta and Jun-O Jin*
DOI: 10.2174/1389200221666201124140518
Published on: 30 December, 2020

Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study

Volume:21   Issue: 14
Pp: 1152-1160
Imadeldin Elfaki*, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr and Salem Abd El-Hadi Habib
DOI: 10.2174/1389200221999201027200931
Published on: 30 December, 2020

Different Effects of Polymorphic Flavin-Containing Monooxygenase 3 and Cytochrome P450 2A6 Activities on an Index of Arteriosclerosis as a Lifestyle-Related Disease in a General Population in Japan

Volume:21   Issue: 14
Pp: 1161-1164
Mirai Uraoka, Makiko Shimizu, Yoshiki Kuwajima, Ami Mizugaki, Haruka Yokoyama, Kanae Mure and Hiroshi Yamazaki*
DOI: 10.2174/1389200221666201009140802
Published on: 30 December, 2020

Acknowledgements to Reviewers free to download

Volume:21   Issue: 14
Pp: 1165-1166

DOI: 10.2174/138920022114201230145959
Published on: 30 December, 2020